Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 5S ribosomal pseudogene 223 (RNA5SP223) is a human pseudogene that resembles the 5S ribosomal RNA gene but is no longer functional due to sequence defects or mutations. It does not code for a functional RNA or protein and is not involved in normal ribosome biogenesis or cellular biological activities. Pseudogenes such as RNA5SP223 are generally considered "genomic fossils" and do not serve as drug targets or biomarkers, though rare pseudogenes may exert regulatory effects on gene expression by acting as competing endogenous RNAs or through other non-coding RNA mechanisms. No such role is established for RNA5SP223. This entity is not a receptor, enzyme, transporter, or any established therapeutic target class—it is a pseudogene. Pseudogenes are non-functional DNA sequences that derive from once-functional genes but have lost their coding potential, commonly due to mutations. The parental 5S ribosomal RNA gene encodes a non-coding RNA important for ribosome structure and function; however, pseudogenes such as RNA5SP223 do not perform this function. RNA, 5S ribosomal pseudogene 223 has not been implicated in disease or therapy and is not associated with any drugs or mechanisms of therapeutic action. In summary, RNA5SP223 is a nonfunctional ribosomal RNA pseudogene in humans, not an active biological target, not involved in coding protein or RNA, and has no current relevance as a drug target, biomarker, or disease role.
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 5S ribosomal pseudogene 223 (RNA5SP223).